|
|
 |
International Operations
Exploring international opportunities for growth
Calpis international operations reflect a strategy based on the needs of each regional market. We will continue expanding our business and exploring new business opportunities through our unique beverage products such as CALPIS, and through alliances with overseas partners utilizing our proprietary microorganism technology and intellectual property.
Calpis will continue providing products that contribute to health in body and mind for people across the world.
Asian Markets |
|
Our beverage business monitors both regional characteristics and health trends
Calpis’ first business in Asia was its Indonesian operations, which started in 1994. This was followed by operations in Taiwan and Thailand to provide products which meet the needs of the consumer.
We also established a representative office in Shanghai in 2005, followed by Vietnam in 2006, to start up marketing operations and aggressively expand into new markets.
As there is an increasing awareness of the importance of health across Asia, we are committed to providing high-quality functional food and beverages and further expanding our business. |
P.T. Ajinomoto Calpis Beverage Indonesia founded in 1994 |
|
Ajinomoto Calpis Beverage (Thailand) Co., Ltd. founded in 1997 |
|
Taiwan Calpis Co. Ltd. founded in 1995 |
|
Japan Calpis Co. Ltd. Shanghai Office founded in 2005 |
|
European and U.S. markets |
|
Calpis U.S.A., Inc. founded in 1991 |
Further cultivating the market for health functions
Our beverage business operated under the CALPICO brand has been performing strongly, especially in Asian markets. We will continue to implement aggressive marketing measures toward further expanding those markets.
Meanwhile, we have started the test marketing of AMEAL S, a dietary supplement based on consumer demand that has been test-marketed in the Northern California market since 2003 and launched as “ameal bp”. We will pursue proactive communication strategies including PR activities targeting physicians toward reaching the entire U.S. market in 2007.
In 2005, in the United States and Europe, we began marketing healthy blood pressure ingredient AmealPeptide and licensing Calpis intellectual property rights. These activities marked a new beginning for Calpis in terms of new markets and new challenges and promote our other functional food ingredients. |
|
